Gavi, the Vaccine Alliance
Budget
€100 — €0
EP Access
0
accredited persons
Staff
2
1 FTE
EU Grants
€135,000,000
Mission & Goals
Gavi’s mission is: “Saving children’s lives and protecting people’s health by increasing equitable use of vaccines in lower-income countries." The Gavi Alliance promotes health by: (i) providing vaccines and the means to deliver such vaccines to people in the poorest countries; (ii) facilitating the research and development of vaccines of primary interest to the developing world; and (iii) providing support in connection with achieving the foregoing purposes by helping to strengthen health care systems and civil societies supporting such purposes in the developing world. Gavi co-led COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator.
EU Legislative Interests
European Consensus on Development EU Strategy on Africa EU Global Health Strategy Global Gateway MAV+ Initiative Global COVID-19 vaccine response EU Global Health Resilience Initiative The EU Medical Countermeasures Strategy
Communication Activities
Global Gateway Summit Global Health Policy Forum Regular calls with DG INTPA (donor calls)
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
The Board is comprised of 18 “representative” seats, 9 seats for independent or “unaffiliated” individuals and one seat for Gavi's CEO. The Board’s representative seats ensure that institutions and constituencies can provide formal input into the development of all Gavi’s policies and the management of its operations. UNICEF, WHO, the World Bank and the Bill & Melinda Gates Foundation hold permanent seats on the Board. Constituency representatives serve on a time-limited basis. Board members include representation from donor governments, implementing country governments, civil society organisations and the vaccine industry. Independent Board members are private individuals with no professional connection to Gavi’s work. They bring independent and balanced scrutiny to all of the Board’s deliberations. These individuals also provide expertise in a number of critical areas such as investment, auditing and fundraising.
Organisation Members
The Gavi Board is responsible for strategic direction and policy-making, oversees the operations of the Vaccine Alliance and monitors programme implementation. With membership drawn from a range of partner organisations, as well as experts from the private sector, the Gavi Board provides a forum for balanced strategic decision making, innovation and partner collaboration. Gavi partners are represented through 18 seats on the Board with nine seats reserved for independent or unaffiliated individuals. Committees support the development of key policies, oversee specific activities and are comprised of Board members, alternates, and in some instances delegates with expertise in critical areas. The Board is the supreme governing body of Gavi, the Vaccine Alliance. Certain functions are reserved to the Board, including the setting of policies and strategies for Gavi, and amending its by-laws and other internal guidelines and procedures necessary for the administration and management of the Vaccine Alliance. The Board delegates certain activities and areas of work to five standing Board committees and one Advisory committee, staffed by Board members, alternates, and in certain instances independent experts or partner representatives. The committees include: • Programme and Policy Committee; • Governance Committee; • Investment Committee; • Audit & Finance Committee; and • Evaluation Advisory Committee.
Additional Information
EU 13 2nd Instalment Nov-24 EUR 135,000,000.00 EC AVMA 2025 Instalment Dec-25 EUR 185,400,000.00 EC HSS 6.0 2025 Instalment Dec-25 EUR 4,500,000.00 EC HSS 6.0 2025 Instalment Dec-25 EUR 10,500,000.00
Commissioner Meetings
No recorded meetings with EU commissioners.